Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

Time: 9:00 am
day: Day Two


  • CBD and its metabolites but not congeneric cannabinoids, potently block SARS-CoV-2 replication in lung epithelial cells
  • CBD acts after cellular infection, inhibiting viral gene expression and upregulating the interferon antiviral signaling pathway
  • A cohort of human patients previously taking CBD had significantly lower SARS-CoV-2 infection incidence of up to an order of magnitude relative to matched pairs or the general population